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registry of the Intermountain Heart Collaborative Study and found to have significant 
CAD (_>70% in at least one major artery). Genofyping used PCR followed by restriction 
enzyme digestion and detection by ethidium bromide staining and gel electrophoresis. 
Patients were grouped according to their ABCA1 and PPAR7 genotypes and followed for 
clinical events for up to 5.8 years (mean, 2.2±1.5 years). 
Results: Average patient age was 65±11 years and 76% were male. ABCA1 genotype 
frequencies were 0.53, 0.39, and 0.08 for GG, AG, and AA, respectively, and for PPARy 
were 0.75, 0.23, and 0.02 for CC, CT, and 13, respectively; each was in Hardy-Weinberg 
equilibrium. In Cox regression, no ABCA1 nor PPARy allele predicted death/MI (all 
p=NS). The combination of the ABCA1 allele (homozygous or heterozygous) with 
homozygosify for the PPARy C allele carried a modest but significant risk of deeth/MI 
compared to the combined GG/CC genotype (univariate HR = 1.44, p=0.008; adjusted 
HR=1.35, p=0.03). No other ABCA1/PPARy combination increased risk for events. 
Concluaions: Individually, neither ABCA1 nor PPAR-y polymorphisms were significantly 
associated with risk for events; however, in combination, the PPARy (C161T) and 
ABCA1(G596A) variants significantly elevate risk for events. This observed synergy 
between two genes related to lipid metabolism requires confirmation and further study. 
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Framingham Risk Equation 
Enrioue F. Schisterm~.rh Scott Grundy, Silvana Lawvere, Heidi Granser, John D. 
Fdedman, Daniel S. Berman, Cedars-Sinai Medical Center, Los Angeles, California. 
Background: The standard Framingham score (SFS) for predicting hard events is strongly 
weighted by age. The extent of coronary atherosclerosis increases with age, however there 
is large inter-individual variability in the rate of progression among those with disease. Elec- 
tron beam tomography (EBT) provides a method for assessing coronary plaque burden, 
thus offering the possibility of estimating a coronary age equivalent and using this modified 
age in place of chronological age. 
Methods: 5,686 consecutive patients who had EBT between Aug. 1998 and Dec. 2000 
were evaluated. CCS was calculated from EBT by the Agatston scoring technique, individ- 
ual modified age, based on the CCS, was calculated as the age at which an individuals cal- 
cium score was at the gender-matched 50th percentile based on previously published 
tables (Raggi et aL Circulation. 101(8):850-5). We incorporated the modified age in place of 
chronological age into the SFS creating a modified Framingham score (MFS). Three 10- 
year risk of hard events categories were calculated for the SFS and the MFS: 0-10 %, >10- 
20%, and >20%. Misclassification tables, means and Spearman correlations were com- 
puted. T-tests and Chi-square tests were used for mean and proportion comparisons, 
respectively. 
Results: As expected, age was significantly different by risk category in the SFS. However, 
no significant differences in age were observed in the three MFS risk categories. The corre- 
lation of SRS and MFS was 0.76 (p<0.001). Only, 1% of the SFS low risk group was reclas- 
sified as high risk by the MFS. 50% of the SFS intermediate patients were reclassified. Of 
those reclassified 18% became high risk and 32% were converted into the low risk MFS 
group. 33% of the high-nsk individuals based on SFS were reclassified to the lower dsk 
groups. Compared to SFS, the MFS classified 3 times as many patients as SFS in the 
high-risk category. Conclusion: Based on this method, we reclassified 48 % of the individu- 
als in intermediate and high-risk group. Our method of reclassification suggests that CCS 
in low risk SFS individuals does not change risk assessment. However, CCS has the 
potential to improve risk prediction for patients with intermediate or high SFS risk. 
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Beniamin D. Home, Joseph B. Muhlestein, Chloe A. Allen Maycock, John F. Carlquist, 
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Background: The Framingham Heart Study described risk factors fundamental to our 
current understanding of coronary artery disease (CAD) development. Although the 
Framingham Risk Model was built as a predictor of CAD onset (ROC area: 0.72 for 
women, 0.69 for men), current guidelines for prevention and treatment of future compli- 
cations (eg. mortality) among patients with existing CAD largely utilize that model. This 
study evaluated predictive risk models for CAD onset and for CAD mortality to determine 
differences in the predictive value of the Framingham risk factors for these two out- 
comes. 
Methods: A cohort of 4,238 patients was evaluated by coronary angiogrephy at the LDS 
Hospital, of which 3,098 (73%) had significant CAD (->1 lesion of >_70% stanosis) and 
1,097 (27%) had no CAD (all stenoses <10%). Of the 3,098 CAD patients, the first 2,585 
possessed 6-year mortality status of which 250 (9.7%) died. Demographic and cardiac 
risk factors were measured at the time of angiography; the design was cross-sectional for 
the CAD endpoint, but was prospective for mortality. 
Results: Predictive risk models were built using dsk scores based on regression [) val- 
ues. For CAD onset, logistic regression showed that age (dsk scores: <45 years [yr]= 0, 
45-49 yr = 2, 50-59 yr = 3, 60-64 yr = 5, 65-69 yr = 7, 70-74 yr = 8, >75 yr = 22), gender 
(male = 6), hypertension (yes = 1), hyperlipidemia (yes = 3), diabetes (yes = 2), and 
smoking (yes = 1) were significant predictors (all p<0.05). For CAD prediction, the ROC 
area was 0.746 with these risk scores. However, prediction of mortality by Cox regres- 
sion among patients with CAD at baseline showed that only age (<60 yr = 0, 60-64 yr = 2, 
65-69 yr = 3, 70-79 yr = 5, ->80 yr = 9) and diabetes (yes = 2) were predictors, while 
hyperlipidemia (yes = -1) was protective (ROC area for mortality risk scores: 0.689). 
Conclusions: The risk factors from the Framingham Risk Model, although predictive of 
CAD onset, are largely not predictive of long-term mortality among patients who have 
already developed CAD. Predictive mortality risk models that are built on population- 
based data from patients with existing CAD may provide better data for guiding therapy 
than does the use of risk models built to predict CAD onset. 
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BACKGROUND: Although the current smoking habit has been established as a major 
risk factor for developing coronary heart disease (CHD) several epidemiological studies 
have shown that the effect of passive smoking on the coronary risk is controversial. Aim 
of this study is to evaluate the role of passive smoking in the dsk of developing acute cor- 
onary syndromes (ACS). 
METHODS: Dudng 2000-01, we studied 848 male and female patients (32 to 76 years 
old) with first event of ACS and 1078 cardiovascular disease free controls, paired by sex 
and age. All the subjects were randomly selected from several Greek regions. Among 
several risk factors we evaluated, based on conditional logistic regression analysis, the 
effect of passive smoking (degree and duration) in the development of ACS. 
RESULTS: 317 (37%) of the patients and 242 (22%) of the controls were defined as non- 
smokers - passive smokers subjects. The analysis showed that non-smokers exposed to 
smoke had 20% higher coronary dsk (OR=1.20, 95% CI, 1.08-1.33, P<0.01) compared 
with non-smokers not exposed to smoke. Additionally, expose to husbands smoke 
increases by 78% the coronary risk in females (OR=1.78; 95 % CI 1.23 to 2.24, P- 
value<0.05). Also, passive smoking plays an additive role in the aetiology of ACS, since it 
was found to increase progressively the coronary risk in the presence of hypartension -
hypereholestarolemle - diabetes mellitus (P for trend<0.001). Finally, a significant ddse- 
response association was identified, showing that, approximately, 25 out of 125 non- 
smokers, who were exposed to the smoke up to one cigarette pack per day and 50 out of 
150 of those who were exposed to the smoke of more than one pack per day, will 
develop ACS, sometime in their life. 
CONCLUSIONS: Given the high prevalence of cigarette smoking among individuals in 
Mediterranean populations, the consequences of passive smoking to public health, 
regarding coronary heart disease, seems to be notable and becomes a major target for 
intervention. 
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Women and Elderly Heart Failure Patients 
Grace L. Smith, Martha J. Radford, Saif S. Rathore, Judith H. Lichtman, Suzanne G. 
Watnick, Harlan M Krumholz, Yale University School of Medicine, New Haven, 
Connecticut. 
Background: Elevated creatinine (Cr) in heart failure (HF) patients (pts) predicts 
increased mortality, but risks in specific patient subgroups are not clear. 
Methods: In 7,788 outpatients from the Digitalis Investigation Group trial, we examined 
how baseline Cr predicted 1 -year all-cause and HF death, after adjusting for body mass 
index, etiology, blood pressure, ejection fraction, New York Heart Association class, dia- 
betes, pulmonary edema, and medications. Models were stratified by sex and age (>=75, 
<75 years). Reported hazard ratios (HR) compare pts with Cr>=1.5 to pts with Cr<l.0 
(rag/alL). 
Reauns: The sample was 75% men, 16% >=75 years, and median Cr 1.2. Higher Cr pre- 
dicted worse outcomes: 24% of pts with Cr>=1.5 died, compared to 12% with Cr 1.1 to 
1.4 and 10% with Cr<=l.0. Associations between Cr and death were modified by both 
sex and age (p<0.001 for interactions), but effects were not additive. Highest risks were 
in women and elderly: For all-cause death, HR= 2.3 (95% confidence interval (CI) 
1.4,3.6) in women compared to HR=I.5 (1.1,2.1) in men; HR=I.8 (1.0,3.1) in pts >=75 
compared to HR=I.5 (1.1,2.1) in pts<75. For HF death, HR=5.9 (3.1,11.2) in women 
compared to HR=2.4 (1.5, 4.0) in men; HR=4.5 (1.6, 12.5) in pts>=75 compared to 
HR=2.4 (1.6,3,8) in pts<75. 
Conclusion: Cr >=1.5 strongly predicts mortality in HF outpatients, especially women 
and older pts. Use of Cr as an indicator of renal function in clinical settings and future 
studies should stratify for age and sex to avoid underestimating risks. 
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